Product Information

OXCARBAZEPINE 300 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1637 per EA under NDC 51991005405. Its NADAC has been published 54 times since Aug 13, 2025.

FDA first approved this application on Jan 11, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG TABLET

OXCARBAZEPINE
$0.1637per EA

Strength

300 mg/1

NDC

51991005405

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078069

FDA Approved

1/11/2008

TE Code

AB

On Market Since

1/11/2008

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 54 times since Aug 13, 2025, and over the history we have for it it has declined 6.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1637 per EA
All-time high$0.1749 (Aug 13, 2025)
All-time low$0.1635 (Jul 22, 2026)
52-week high$0.1747
52-week low$0.1635
Median price$0.1704
Average price$0.1700
Largest weekly change-1.9% (Feb 18, 2026)
Weeks tracked54
Tracking sinceAug 13, 2025

Price History

1W

+0.1%

1M

+0.1%

3M

-1.7%

6M

-3.2%

1Y

-6.3%

3Y

N/A

5Y

N/A

All

-6.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1637 per EA (NDC 51991005405), effective Aug 19, 2026.

How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 6.4%. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?

Since Aug 13, 2025, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1635 (Jul 22, 2026) to a high of $0.1749 (Aug 13, 2025), with a median of $0.1704 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXCARBAZEPINE 300 MG TABLET?

OXCARBAZEPINE 300 MG TABLET (NDC 51991005405) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.